GA

General Atlantic Portfolio holdings

AUM $2.87B
1-Year Est. Return 70.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.87B
AUM Growth
-$458M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$70.4M
2
+$43.6M
3
+$22.2M

Top Sells

1
+$272M
2
+$200M
3
+$90.3M
4
BULL
Webull Corp
BULL
+$71.9M
5
RPRX icon
Royalty Pharma
RPRX
+$52.9M

Sector Composition

1 Technology 52.16%
2 Healthcare 33.17%
3 Financials 12.93%
4 Consumer Staples 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLO icon
1
dLocal
DLO
$3.61B
$660M 22.97%
46,656,695
CHYM
2
Chime Financial
CHYM
$8.29B
$535M 18.63%
21,259,683
+2,050,923
XP icon
3
XP
XP
$11.1B
$372M 12.93%
22,699,133
-2,818,600
ALKT icon
4
Alkami Technology
ALKT
$1.74B
$277M 9.63%
11,991,480
ALHC icon
5
Alignment Healthcare
ALHC
$3.85B
$260M 9.05%
13,167,733
-11,119,494
RVMD icon
6
Revolution Medicines
RVMD
$19.7B
$224M 7.8%
2,812,928
+338,500
PHVS icon
7
Pharvaris
PHVS
$1.84B
$223M 7.76%
8,031,252
CNTA
8
Centessa Pharmaceuticals
CNTA
$3.97B
$153M 5.33%
6,117,715
-3,564,103
NRIX icon
9
Nurix Therapeutics
NRIX
$1.64B
$92.9M 3.23%
+4,897,159
EWCZ icon
10
European Wax Center
EWCZ
$252M
$47.2M 1.64%
13,110,492
RSKD icon
11
Riskified
RSKD
$684M
$26.5M 0.92%
5,324,998
GROV icon
12
Grove Collaborative
GROV
$58.4M
$2.72M 0.09%
2,474,859
BULL
13
Webull Corp
BULL
$2.92B
$395K 0.01%
50,816
-7,148,051
ADAG
14
Adagene
ADAG
$140M
– –
-3,782,339
AKRO
15
DELISTED
Akero Therapeutics
AKRO
– –
-5,733,989
RPRX icon
16
Royalty Pharma
RPRX
$19.8B
– –
-1,500,000
ALMS
17
Alumis Inc
ALMS
$3.7B
– –
-1,297,530